HIGHLIGHTS
- who: Jose I. Bernardino and colleagues from the Editor: Alan Landay, Rush University, UNITED , Department of infectious diseases, CHU de Nantes and CIC, INSERM, Nantes, France have published the paper: Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0209911]. January 28, 2019 of /1371/
- what: In the present analysis the authors report a statistically significant greater increase in body mass index and trunk fat . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.